Similarly, exogenous IL-33 application provides a mechanistic rationale for EoE development in mice, promoting transmural eosinophilia, mucosal hyperproliferation, upregulation of eosinophilic genes and chemokines, and the inhibition of the regulatory T cell with loss of antigenic tolerance [102]. This evidence concerns the gene IL33 and Increased total eosinophil count.